Cargando…

Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery

BACKGROUND: For adults undergoing complex, multilevel spinal surgery, tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss. The optimal dosing of intravenous TXA remains unclear. This systematic review and meta-analysis compare various dosing regimens of intravenous TXA used...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmani, Roman, Singleton, Amy, Fulton, Zachary, Pederson, John M., Andreshak, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820071/
https://www.ncbi.nlm.nih.gov/pubmed/35141651
http://dx.doi.org/10.1016/j.xnsj.2021.100086
_version_ 1784646171188264960
author Rahmani, Roman
Singleton, Amy
Fulton, Zachary
Pederson, John M.
Andreshak, Thomas
author_facet Rahmani, Roman
Singleton, Amy
Fulton, Zachary
Pederson, John M.
Andreshak, Thomas
author_sort Rahmani, Roman
collection PubMed
description BACKGROUND: For adults undergoing complex, multilevel spinal surgery, tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss. The optimal dosing of intravenous TXA remains unclear. This systematic review and meta-analysis compare various dosing regimens of intravenous TXA used in patients undergoing multilevel spine surgery (≥2 levels). METHODS: PubMed, Cochrane, and EMBASE databases were searched for English language studies published January 2001 through May 2021 reporting use of TXA versus placebo for multilevel spine surgery. Primary outcomes of interest were intraoperative blood loss volume (BLV) and total BLV. A separate random effects model was fit for each outcome measure. Effect sizes were calculated as pooled mean differences (Diff) with corresponding 95% confidence intervals (CIs). Random effects network meta-analyses assessed whether the specific TXA dosing regimen influenced BLV. RESULTS: Seven studies with 441 patients were included for meta-analysis. Four different TXA dosing regimens were found: 1) 10 mg/kg + 1 mg/kg/h, 2) 10 mg/kg + 2 mg/kg/h, 3) 15 mg/kg, 4) 15 mg/kg + 1 mg/kg/h. Compared to placebo, patients treated with TXA had reduced intraoperative BLV (Diff = -185.0 ml; 95% CI: -302.1, -67.9) and reduced total BLV (Diff = -439.0 ml; 95% CI: -838.5, -39.6). No significant differences in intraoperative BLV among any of the TXA treatment groups was found. Patients given a TXA dose of 15 mg/kg + 1 mg/kg/h had significantly reduced total BLV in comparison to both placebo (Diff = -823.1 ml; 95% CI: -1249.8, -396.4) and a dose of 15 mg/kg (Diff = -581.2; 95% CI: -1106.8, -55.7). CONCLUSIONS: This study found that intravenous TXA is associated with reduced intraoperative and total BLV, but it remains unclear whether there is an optimal TXA dose. Additional trials directly comparing different TXA regimens and administration routes are needed.
format Online
Article
Text
id pubmed-8820071
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88200712022-02-08 Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery Rahmani, Roman Singleton, Amy Fulton, Zachary Pederson, John M. Andreshak, Thomas N Am Spine Soc J Systematic Reviews /Meta-analyses BACKGROUND: For adults undergoing complex, multilevel spinal surgery, tranexamic acid (TXA) is an antifibrinolytic agent used to reduce blood loss. The optimal dosing of intravenous TXA remains unclear. This systematic review and meta-analysis compare various dosing regimens of intravenous TXA used in patients undergoing multilevel spine surgery (≥2 levels). METHODS: PubMed, Cochrane, and EMBASE databases were searched for English language studies published January 2001 through May 2021 reporting use of TXA versus placebo for multilevel spine surgery. Primary outcomes of interest were intraoperative blood loss volume (BLV) and total BLV. A separate random effects model was fit for each outcome measure. Effect sizes were calculated as pooled mean differences (Diff) with corresponding 95% confidence intervals (CIs). Random effects network meta-analyses assessed whether the specific TXA dosing regimen influenced BLV. RESULTS: Seven studies with 441 patients were included for meta-analysis. Four different TXA dosing regimens were found: 1) 10 mg/kg + 1 mg/kg/h, 2) 10 mg/kg + 2 mg/kg/h, 3) 15 mg/kg, 4) 15 mg/kg + 1 mg/kg/h. Compared to placebo, patients treated with TXA had reduced intraoperative BLV (Diff = -185.0 ml; 95% CI: -302.1, -67.9) and reduced total BLV (Diff = -439.0 ml; 95% CI: -838.5, -39.6). No significant differences in intraoperative BLV among any of the TXA treatment groups was found. Patients given a TXA dose of 15 mg/kg + 1 mg/kg/h had significantly reduced total BLV in comparison to both placebo (Diff = -823.1 ml; 95% CI: -1249.8, -396.4) and a dose of 15 mg/kg (Diff = -581.2; 95% CI: -1106.8, -55.7). CONCLUSIONS: This study found that intravenous TXA is associated with reduced intraoperative and total BLV, but it remains unclear whether there is an optimal TXA dose. Additional trials directly comparing different TXA regimens and administration routes are needed. Elsevier 2021-10-23 /pmc/articles/PMC8820071/ /pubmed/35141651 http://dx.doi.org/10.1016/j.xnsj.2021.100086 Text en © 2021 Published by Elsevier Ltd on behalf of North American Spine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Systematic Reviews /Meta-analyses
Rahmani, Roman
Singleton, Amy
Fulton, Zachary
Pederson, John M.
Andreshak, Thomas
Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery
title Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery
title_full Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery
title_fullStr Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery
title_full_unstemmed Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery
title_short Tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: A systematic review and network meta-analysis: Tranexamic acid for multilevel spine surgery
title_sort tranexamic acid dosing strategies and blood loss reduction in multilevel spine surgery: a systematic review and network meta-analysis: tranexamic acid for multilevel spine surgery
topic Systematic Reviews /Meta-analyses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820071/
https://www.ncbi.nlm.nih.gov/pubmed/35141651
http://dx.doi.org/10.1016/j.xnsj.2021.100086
work_keys_str_mv AT rahmaniroman tranexamicaciddosingstrategiesandbloodlossreductioninmultilevelspinesurgeryasystematicreviewandnetworkmetaanalysistranexamicacidformultilevelspinesurgery
AT singletonamy tranexamicaciddosingstrategiesandbloodlossreductioninmultilevelspinesurgeryasystematicreviewandnetworkmetaanalysistranexamicacidformultilevelspinesurgery
AT fultonzachary tranexamicaciddosingstrategiesandbloodlossreductioninmultilevelspinesurgeryasystematicreviewandnetworkmetaanalysistranexamicacidformultilevelspinesurgery
AT pedersonjohnm tranexamicaciddosingstrategiesandbloodlossreductioninmultilevelspinesurgeryasystematicreviewandnetworkmetaanalysistranexamicacidformultilevelspinesurgery
AT andreshakthomas tranexamicaciddosingstrategiesandbloodlossreductioninmultilevelspinesurgeryasystematicreviewandnetworkmetaanalysistranexamicacidformultilevelspinesurgery